Regeneron Pharmaceuticals, Inc… (NASDAQ:REGN)

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

While the public wants more pharmaceuticals and biotech advancements to treat the endless number of ailments or to extend their lives, there is a simultaneous push to make drugs more ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Array Bio, Bank of America, Oracle, Pinterest, RingCentral, Snap, SunPower, Twilio, Xilinx and More

Stocks were indicated to open higher on Tuesday after a small gain in the Dow and S&P 500 on Monday. It may be the summer, but investors need to be ...
Read Full Story »

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

When the stock market is hitting record highs, it's important to remember that it's really a market of stocks rather than a stock market. Not all companies are created equal. ...
Read Full Story »

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) have announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of ...
Read Full Story »

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

In an incredible move for adolescent patients 12 to 17 years of age, the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for patients with moderate-to-severe atopic dermatitis. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, CBOE, eBay, Etsy, Intel, Netflix, Nokia, Snap, UTC, Vonage and More

Stocks surged on Friday's strong payrolls report, but that only recaptured some of Thursday's more than 600-point drop in the Dow Jones industrials. Investors have become used to the notion ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

The futures traded down triple digits Friday morning as investors digested a very volatile trading week. Continued positive talk on trade, with China acknowledging the resumption of soybean and oil ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Achaogen, Apple, Athenahealth, Crocs, Disney, Finisar, Jabil, Michael Kors, Occidental, Starbucks and More

Stocks were indicated lower on Monday on additional trade concerns between China and the United States, even with OPEC expected to lower oil production. Investors have seen lower upside after ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

September 27, 2018: The S&P 500 closed up 0.3% at 2,914.07. The DJIA closed up 0.2% at 26,440.41. Separately, the Nasdaq closed up 0.7% at 8,041.97. Thursday was a positive ...
Read Full Story »

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

More and more, the companies that we cover on Wall Street are starting to agree that while the future's still bright for the U.S. economy, it may be one of ...
Read Full Story »

New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial of ...
Read Full Story »

What the FDA Has to Say About Regeneron’s Eylea

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is facing some difficulty after it received an update from the U.S. Food and Drug Administration (FDA). Essentially, the agency issued a complete response letter ...
Read Full Story »

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

It's no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many ...
Read Full Story »

Friday’s Biggest Winners and Losers in the S&P 500

May 11, 2018: The S&P 500 closed up 0.2% at 2,727.69. The DJIA closed up 0.4% at 24,830.04. Separately, the Nasdaq was flat at 7,402.88. Friday was a relatively positive ...
Read Full Story »

Will a PCSK9 Inhibitor Price Cut Help Drive Lowering LDL-Cholesterol Drug Use?

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) and Sanofi S.A. (NYSE: SNY) are committing to lowering the price of the anti-cholesterol drug Praluent. The move may sound right up the lines of ...
Read Full Story »